SYNTHESE VON CANTHARIDIN
European patent · EP4339199 · In force
Register entry
- Publication number
- EP4339199
- Application number
- EP24153182
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 4, 2018
- Published
- Mar 20, 2024
- Granted
- May 20, 2026
- Protection ends at the latest
- Oct 3, 2038
- Next annual fee due
- Oct 31, 2027
- IPC classes
- C07D 333/38 (2006.01)C07D 491/18 (2006.01)C07D 493/18 (2006.01)C07D 495/18 (2006.01)C07D 495/22 (2006.01)C07D 495/04 (2006.01)
- Priority
- US 201762568004 P 04.10.2017
- Divided from
- EP18864069
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.10.2026 → 31.10.2027
Published in Swissreg on 01.11.2026
- May 20, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 20.05.2026
Parties
Inventor
DAVIDSON, Matthew, Gene
Venice, 90291, US
EKLOV, Brian, Matthew
Kalamazoo, 49009, US
WUTS, Peter
Kalamazoo, 49009, US
LOERTSCHER, Brad, Melvin
Portage, 49024, US
SCHOW, Steven, R.
Redwood City, 94065, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.